Medtech companies raised more than $738 million in Q2

Venture capital firms invested more than $738 million during the second quarter of 2018, $1 million less than the first quarter of this year, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There was a total of 61 deals during Q2, an increase from the 48 that the industry saw during Q1.

Avinger receives FDA clearance for Pantheris altherectomy device

Avinger (Redwood City, Calif.) recently received FDA clearance for its Pantheris image guided altherectomy device that is designed to treat peripheral artery disease (PAD). Pantheris is the first medical device to be cleared for diagnostics and treatment of PAD. The device lets doctors see inside arteries to treat blockages. It features a built-in camera and

3D color X-rays could help diagnose cancer, heart disease and more

New Zealand scientists performed the first-ever 3D, color X-rays on a human, using technology that could improve medical diagnostics in oncology, cardiology, neurology and orthopedics. Based on traditional black-and-white X-ray technology, the scanner incorporates the Medipix3RX detector chip, a particle-tracking technology developed for the CERN Large Hadron Collider. It was developed by the Medipix3 Collaboration, which

Digital Surgery touts artificial intelligence for the operating room

Officials at Digital Surgery (London) boast that they have successfully demonstrated a real-time, dynamic artificial intelligence (AI) system designed for the operating room. The patented AI platform includes surgical procedure roadmaps that are meant to aid the surgical team in an OR. The goal is to reduce risk and make surgery safer. “This is a huge milestone for

Medtech stories we missed this week: July 13, 2018

From Angiodroid receiving CE Mark approval to Masimo launching its vital signs app, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Angiodroid wins CE Mark for Angiopulse IABP Angiodroid announced in a July 11 press releasethat it has received CE Mark approval for its AngioPulse intra-aortic balloon pump

Dune Medical debuts waste-saving surgical probe

Dune Medical Devices has designed a reposable version of its MarginProbe radiofrequency spectropscopy device, which can help surgeons identify remaining cancer cells in real time during a lumpectomy. The updated MarginProbe has a  reusable cable and handle and a single-use attachable probe. It has the potential to reduce waste burden of the MarginProbe up to

MedPlast completes Advanced Surgical and Orthopedics acquisition, rebrands as Viant

MedPlast announced that it has finished the acquisition of Integer Holding’s Advanced Surgical and Orthopedics business. The company plans to rebrand as Viant to showcase the new strategic direction. “Today marks an exciting day for our company. The addition of Integer’s business expands our capabilities and offerings and enables us to achieve our goal of

Medtech stories we missed this week: July 6, 2018

From Zetta getting FDA clearance to Prescient Medical receiving CE Mark approval, here are five medtech stories we missed this week but thought were still worth mentioning. 1. Zetta wins FDA clearance for Zoom MRI software Zetta announced in a June 25 press release that its MRI software has received FDA 510(k) clearance. The software, known as

Integer sells advanced surgical, ortho lines to MedPlast

Integer (NYSE:ITGR) has completed the spinoff of its advanced surgical and orthopedics products lines to MedPlast, LLC for $600 million in cash. Announced in May, the deal will double MedPlast’s top line and bolster the balance sheet for Integer, which missed expectations with its first-quarter earnings. MedPlast also announced that it will rebrand under the name

Clot-buster captures tiny particles, too

MIVI Neuroscience’s next-generation DAISe blood clot management system has had its first-in-human use for treatment of ischemic stroke. The procedure took place in South America, the company said in a statement. DAISe is designed to remove a clot as well as filter and capture clot emboli that fracture during removal.  It has a three-dimensional, vessel-conforming

How’d they do that? 7 innovations from medical device contract manufacturers

Charles Darwin wrote, “In the long history of humankind (and animal kind, too) those who learned to collaborate and improvise most effectively have prevailed.” Medical device companies get the credit for many innovations, but many need the ingenuity and commitment of contract manufacturers who design and produce the components that make those big splashes possible.

Pages: 1 2 3 4 5 6 7 8

Study: No difference in complications, survival rate between robot-assisted and open bladder surgeries

A seven-year study comparing outcomes from robotic and open cystectomy procedures showed no statistically significant difference in complications or survival rate between the two methods. The randomized open versus robotic cystectomy study, known as the Razor trial, is touted as the first comprehensive study to compare outcomes between robotic and traditional open surgeries in any […]

Johnson & Johnson launches new self-shortening Dynacord suture

Johnson & Johnson through its DePuy Synthes franchise has announced the U.S. launch of its Dynacord suture for soft tissue repair in areas such as the rotator cuff in the shoulder. The Dynacord suture, available on Healix Advance anchors, is part of the DePuy Synthes Mitek Sports Medicine portfolio. J&J launched Dynacord today at the San

SetPoint Medical touts 2-year relief from rheumatoid arthritis

Startup SetPoint Medical has demonstrated “significant, sustained improvement” over two years in a first-in-human study using bioelectronic therapy in patients with rheumatoid arthritis (RA). Seventeen subjects with moderate to severe symptoms were implanted with a vagus nerve stimulator in the European study. At three months, the therapy was shown to have significantly reduced RA symptoms

Bay Labs wins FDA clearance for AI-based echocardiogram analysis

Bay Labs has received 510(k) clearance from U.S. FDA for use of its EchoMD AutoEF software product to provide fully automated clip selection and calculation of left ventricular ejection fraction (EF), the San Francisco–based company said today. The EF is the percentage of blood leaving a heart each time it contracts. Bay Labs in its news release